(Q83094715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Pathology of nonalcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

1

Elizabeth M Brunt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

2 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

195-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.21

19 January 2020

exact match

0 references

cites work

Obesity and diabetes in the developing world--a growing challenge

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

The epidemiology of nonalcoholic fatty liver disease: a global perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Epidemiology and natural history of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Update on nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Adipokines in liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Long-term follow-up of patients with nonalcoholic fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic fatty liver disease in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Long-term follow-up of patients with NAFLD and elevated liver enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Ethnic differences in hepatic steatosis: an insulin resistance paradox?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Is NASH underdiagnosed among African Americans?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Influence of ethnicity on histological differences in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nutrition and nonalcoholic fatty liver disease in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Silent non-alcoholic fatty liver disease-a clinical-histological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic fatty liver disease in children: a single center experience.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

New imaging techniques for non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Methods for assessing intrahepatic fat content and steatosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Non-alcoholic fatty liver disease: is bariatric surgery the answer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Liver fibrosis in overweight patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Sources of variability in histological scoring of chronic viral hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic fatty liver disease: pathology and pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Autophagy regulates lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Kupffer cell aggregation and perivenular distribution in steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Alcoholic and nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Hepatocellular carcinoma: epidemiology, risk factors, and screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Two cases from the spectrum of nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Advances in pediatric nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Prevalence of fatty liver in children and adolescents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Histopathology of pediatric nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.21

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

31 March 2020

1 reference

12 December 2020

Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations

1 reference

12 December 2020

Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort

1 reference

12 December 2020

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease

1 reference

12 December 2020

Liver biopsy sampling in chronic viral hepatitis

1 reference

12 December 2020

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

1 reference

12 December 2020

Dysmetabolic iron overload syndrome

1 reference

12 December 2020

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

1 reference

12 December 2020

The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

12 December 2020

Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

1 reference

12 December 2020

Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients

1 reference

12 December 2020

Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2010.21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20195271%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference